Business Description
Chemomab Therapeutics Ltd
NAICS : 541714
SIC : 8731
ISIN : US16385C1045
Share Class Description:
CMMB: ADRDescription
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 40.71 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -58.7 | |||||
3-Year EPS without NRI Growth Rate | -56.2 | |||||
3-Year FCF Growth Rate | -61.2 | |||||
3-Year Book Growth Rate | 6.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.12 | |||||
9-Day RSI | 58.04 | |||||
14-Day RSI | 56.48 | |||||
6-1 Month Momentum % | 102.15 | |||||
12-1 Month Momentum % | -19.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.83 | |||||
Quick Ratio | 3.83 | |||||
Cash Ratio | 3.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.9 | |||||
Shareholder Yield % | -0.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -58.99 | |||||
ROA % | -45.52 | |||||
ROIC % | -502.95 | |||||
ROC (Joel Greenblatt) % | -2045.61 | |||||
ROCE % | -60.49 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.21 | |||||
Price-to-Tangible-Book | 1.21 | |||||
EV-to-EBIT | 0.02 | |||||
EV-to-EBITDA | 0.02 | |||||
EV-to-FCF | -0.02 | |||||
Price-to-Net-Current-Asset-Value | 1.33 | |||||
Price-to-Net-Cash | 1.45 | |||||
Earnings Yield (Greenblatt) % | 5000 | |||||
FCF Yield % | -91.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CMMB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chemomab Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1 | ||
Beta | 0.12 | ||
Volatility % | 76.94 | ||
14-Day RSI | 56.48 | ||
14-Day ATR ($) | 0.098121 | ||
20-Day SMA ($) | 0.99784 | ||
12-1 Month Momentum % | -19.86 | ||
52-Week Range ($) | 0.42 - 1.46 | ||
Shares Outstanding (Mil) | 14.22 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chemomab Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chemomab Therapeutics Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Chemomab Therapeutics Ltd Frequently Asked Questions
What is Chemomab Therapeutics Ltd(CMMB)'s stock price today?
The current price of CMMB is $1.13. The 52 week high of CMMB is $1.46 and 52 week low is $0.42.
When is next earnings date of Chemomab Therapeutics Ltd(CMMB)?
The next earnings date of Chemomab Therapeutics Ltd(CMMB) is 2024-08-31 Est..
Does Chemomab Therapeutics Ltd(CMMB) pay dividends? If so, how much?
Chemomab Therapeutics Ltd(CMMB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |